entertainment -WSS

entertainment

author：explore 2025-09-30 20:26:29 - browse：564

PHOTO: Vans gluten free waffles. — Vans gluten free waffles.USFDA

Gluten-free breakfast fans, check your freezer to ensure this newly recalled frozen waffle brand doesn't make it to the toaster.

On Monday Van’s International Foods issued a voluntary recall with full knowledge and cooperation of the U.S. Food and Drug Administration (FDA) that some of its gluten free waffles may contain undeclared wheat.

"People who have an allergy or severe sensitivity to wheat run the risk of serious or life-threatening allergic reaction if they consume these products," the company said.

The recalled products have Lot Code #UW40193L on the packaging with an expiration date of 1/19/2024.

"To identify the Lot Code and expiration date, please refer to the side of the carton. Consumers who believe they have purchased recalled lot code product are urged to confirm the lot code with place of purchase," the company said.

Click here for more label and product images from the FDA.

No other Van’s products were part of this recall and no allergic reactions or illnesses associated with consumption of the affected product have been reported, according to Van's.

Van's said the recall was "initiated in an abundance of caution due to potential presence of wheat in certain products labeled as gluten-free."

"The recall was initiated after it was discovered that wheat-containing product was distributed in packaging that did not reveal the presence of wheat," the recall notice said. "Subsequent investigation indicates that the problem was caused by the inclusion of a limited number of cartons for Van’s Gluten Free Original Waffles with a pallet of cartons intended for wheat containing products. Immediate steps were taken to prevent recurrence."

Consumers who may have the affected products can dispose of the waffles or return it to the place of purchase for a full refund.

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： 10 reasons why health care startups fail

WSS

How digital tools helped lower hypertension in marginalized patients

Industry veterans launch new biotech VC with $310M

How digital tools helped lower hypertension in marginalized patients

Boston competes with Raleigh

Philips to halt sales of sleep apnea machines in U.S.

Reconstructing family trees of blood cells may help predict disease

knowledge

entertainment

focus

As demand for Covid shots wanes, Moderna seeks its next success

Bernie Sanders is gearing up to subpoena pharma CEOs

The cancer drug shortage isn’t new — and neither are the solutions

Why you shouldn’t ask, “What country has the best health care?”

What does generative AI mean for health care? We asked experts

Boston competes with Raleigh

DIEP, the 'gold standard' of breast reconstruction, is under threat

A disappointing year of Humira biosimilars

Trump demands the U.S. pay no more for drugs than other countries … again

How generative AI ratchets up security threats for health systems

hotspot

Boston competes with Raleigh

To avoid data mishandling cases, universities eye AI and other tools

Medical mystery: When a cough is not just a cough

Medicare threatens to cut off funding for HCA's Mission hospital

Zyn nicotine pouches become unlikely player in latest culture war

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

focus

explore

explore

hotspot